Recent time trends in uterine cancer

Area of Science:

• Oncology
• Epidemiology
• Endocrinology

Background:

• Corpus uterine cancer remains a significant health concern.
• Understanding trends in incidence, hospitalization, and related factors is crucial for public health.
• Exogenous hormone use has been a subject of investigation regarding its impact on gynecological health.

Purpose of the Study:

• To analyze recent trends in corpus uterine cancer incidence and hospitalization rates.
• To examine trends in the use of exogenous hormones during the same period.
• To explore potential associations between hormone use and uterine cancer trends.

Main Methods:

• Utilized data from the Surveillance and End Results Program (SEER) for cancer incidence (1979-1986).
• Employed National Hospital Discharge Surveys (NHDS) data for hospitalization trends (1979-1986).
• Analyzed National Ambulatory Medical Care Surveys (NAMCS) data for exogenous hormone use patterns (1980, 1981, 1985).

Main Results:

• Corpus uterine cancer incidence rates showed a continued decline since 1979, with accelerated decrease post-1983-84.
• Hospitalizations for uterine cancer also declined, with a marked acceleration after 1983-84.
• Significant increases in exogenous hormone use were observed, with a ~700% rise in progesterones and 7-22% in estrogens.

Conclusions:

• The declining trends in uterine cancer incidence and hospitalizations may be linked to shifts in exogenous hormone usage patterns.
• Further investigation is warranted to elucidate the complex relationship between specific hormone therapies and uterine cancer.
• These findings highlight the importance of monitoring epidemiological data alongside pharmaceutical trends.